Viewing Study NCT01739660


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-02-20 @ 8:32 AM
Study NCT ID: NCT01739660
Status: COMPLETED
Last Update Posted: 2013-10-25
First Post: 2012-11-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis
Sponsor: Savient Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module